Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
XBB.1.9.2EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
XBB.1.9.2EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
XBB.1.9.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.9.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FL.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
FL.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FL.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
FL.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
FL.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
FL.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
FL.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FL.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FY.1.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
FY.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FY.1.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
FY.1.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
FY.1.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
FY.1.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
FY.1.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FY.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.2.3.20EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
XBB.2.3.20EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.2.3.20ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
XBB.2.3.20ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
XBB.2.3.20EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
XBB.2.3.20EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
XBB.2.3.20ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.2.3.20ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
EG.5.2.2EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
EG.5.2.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
EG.5.2.2ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
EG.5.2.2ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
EG.5.2.2EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
EG.5.2.2EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
EG.5.2.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
EG.5.2.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
HK.27EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
HK.27EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HK.27ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
HK.27ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
HK.27EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
HK.27EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
HK.27ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
HK.27ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
HK.30EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
HK.30EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HK.30ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
HK.30ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
HK.30EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
HK.30EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used